MMSNYSEServices-Business Services, NECFiscal year ends September 30
MAXIMUS, INC.
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$61.33−0.14 (-0.23%)
Close on Oct 19, 2026
- Market cap
- $3.25B
- P/E (TTM)
- 9.1
- Dividend yield
- 1.96%
MAXIMUS, INC. revenue by segment
By business segment
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| U.S. Federal Services | $3.07B | $2.74B | $2.40B | $2.26B | $1.89B | $1.63B | $1.11B | $478.91M | $545.57M | $591.73M | 56.5% | +12.1% |
| U.S. Services | $1.76B | $1.91B | $1.81B | $1.61B | $1.66B | $1.33B | $1.18B | $1.21B | – | – | 32.5% | -7.7% |
| Outside the U.S. | $599.89M | $657.14M | $689.05M | $763.66M | $699.09M | $498.93M | $599.13M | – | – | – | 11.0% | -8.7% |
| Human Services | – | – | – | – | – | – | – | $508.37M | $525.24M | $513.33M | – | – |
| Health Services | – | – | – | – | – | – | – | $1.40B | $1.38B | $1.30B | – | – |
| U.S. Health & Human Services | – | – | – | – | – | – | $1.18B | $1.21B | $1.22B | – | – | – |
| Outside the U.S. | – | – | – | – | – | $498.93M | $599.13M | $699.41M | $685.30M | – | – | – |
| Operating income | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|
| U.S. Federal Services | – | $333.62M | $249.69M | $234.93M | $189.07M | $132.90M | $115.94M | $57.39M | $64.98M | $63.38M | – |
| U.S. Services | – | $246.98M | $182.55M | $182.10M | $254.44M | $227.78M | $220.83M | $218.63M | – | – | – |
| Outside the U.S. | – | $7.71M | -$9.13M | -$15.17M | $20.13M | -$34.13M | $16.06M | – | – | – | – |
| Human Services | – | – | – | – | – | – | – | $18.22M | $48.58M | $47.69M | – |
| Health Services | – | – | – | – | – | – | – | $236.38M | $215.24M | $185.03M | – |
| U.S. Health & Human Services | – | – | – | – | – | – | $220.83M | $218.63M | $204.89M | – | – |
| Outside the U.S. | – | – | – | – | – | -$34.13M | $16.06M | $35.97M | $58.94M | – | – |
By product or service
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Program Operations | $2.65B | $2.57B | $2.50B | $2.50B | $2.76B | $2.40B | – | – | – | – | 48.8% | +3.1% |
| Clinical Services | $2.10B | $1.89B | $1.49B | $1.18B | $699.42M | $539.02M | – | – | – | – | 38.7% | +11.1% |
| Employment & Other | $354.84M | $469.30M | $520.98M | $551.76M | $463.70M | $318.43M | – | – | – | – | 6.5% | -24.4% |
| Technology Solutions | $324.73M | $375.11M | $397.03M | – | – | – | – | – | – | – | 6.0% | -13.4% |
| Technology Solutions | – | $375.11M | $397.03M | $400.56M | $335.55M | $208.47M | – | – | – | – | – | – |
By region
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Australia | – | – | – | $173.08M | $245.00M | $147.16M | $198.80M | $247.85M | $232.43M | $200.54M | – | – |
| United States | – | – | – | $3.87B | $3.56B | $2.96B | $2.29B | $1.69B | $1.77B | $1.72B | – | – |
| United Kingdom | – | – | – | $410.59M | $286.43M | $246.33M | $293.70M | $347.03M | $346.34M | $384.65M | – | – |
| Rest of world | – | – | – | $180.00M | $167.66M | $105.44M | $106.64M | $104.54M | $106.52M | $96.91M | – | – |
From the segment and revenue-disaggregation notes of Maximus's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.